New Zealand markets closed

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.72-0.30 (-2.00%)
At close: 04:00PM EDT
14.93 +0.21 (+1.43%)
After hours: 07:39PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
66,917
71,410
83,079
39,482
74,983
Depreciation & amortisation
657
32,881
1,239
192
92
Deferred income taxes
6,397
-17,818
4,937
9,316
-32,971
Stock-based compensation
7,453
14,250
7,907
6,073
6,261
Change in working capital
8,549
-37,324
13,729
5,022
-4,112
Accounts receivable
-2,712
-43,075
-3,820
-632
4,549
Inventory
-182
-4,739
1,065
-3,219
-2,694
Accounts payable
-223
10,820
1,207
-1,488
138
Other working capital
95,076
61,856
116,018
59,351
45,023
Other non-cash items
4,443
82,963
4,147
-5
-12
Net cash provided by operating activities
95,146
143,600
116,047
60,372
45,034
Cash flows from investing activities
Investments in property, plant and equipment
-70
-81,744
-29
-1,021
-11
Purchases of investments
0
-13,465
0
-10,000
-10,000
Sales/maturities of investments
19,238
0
19,238
0
5,000
Other investing activities
-198,293
-198,293
-10,000
-
-
Net cash used for investing activities
9,168
-293,502
9,209
-11,021
-5,011
Cash flows from financing activities
Common stock repurchased
-9,982
0
-6,907
-12,089
0
Other financing activities
-156
-13,649
-968
-153
-56
Net cash used provided by (used for) financing activities
-3,085
-10,857
1,694
-8,143
702
Net change in cash
101,229
-160,759
126,950
41,208
40,725
Cash at beginning of period
154,836
298,395
171,445
130,237
89,512
Cash at end of period
256,065
137,636
298,395
171,445
130,237
Free cash flow
Operating cash flow
95,146
143,600
116,047
60,372
45,034
Capital expenditure
-70
-81,744
-29
-1,021
-11
Free cash flow
95,076
61,856
116,018
59,351
45,023